1 – 6 of 6
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2017
-
Mark
Increased levels of CSF total but not oligomeric or phosphorylated forms of alpha-synuclein in patients diagnosed with probable Alzheimer's disease
(
- Contribution to journal › Article
- 2016
-
Mark
A novel multiplex assay for simultaneous quantification of total and S129 phosphorylated human alpha-synuclein
(
- Contribution to journal › Article
-
Mark
Longitudinal changes in CSF alpha-synuclein species reflect Parkinson's disease progression
(
- Contribution to journal › Article
-
Mark
Oligomeric and phosphorylated alpha-synuclein as potential CSF biomarkers for Parkinson's disease.
(
- Contribution to journal › Article
- 2015
-
Mark
Ser129 phosphorylation of endogenous α-synuclein induced by overexpression of polo-like kinases 2 and 3 in nigral dopamine neurons is not detrimental to their survival and function.
(
- Contribution to journal › Article
-
Mark
Generation and characterization of novel conformation-specific monoclonal antibodies for α-synuclein pathology.
(
- Contribution to journal › Article